[Skip to Content]
[Skip to Content Landing]
February 5, 2019

Achieving Clinical Remission for Patients With Rheumatoid Arthritis

Author Affiliations
  • 1Division of Rheumatology, Department of Medicine, Medical University of Vienna, Austria
JAMA. 2019;321(5):457-458. doi:10.1001/jama.2018.21249

The most important therapeutic goals for treating rheumatoid arthritis (RA) are eliminating signs and symptoms (such as joint pain, swelling, and stiffness); preventing joint damage or its progression; and maximizing physical function and quality of life. These aims are accomplished by achieving disease remission, a state in which no or only minimal residual inflammation is discernible. Today, this goal is attainable in up to 50% of patients with RA, using approved drugs in a treat-to-target strategy.1